We use cookies to make this site work. We'd also like to set optional cookies so we can understand how the site is used and improve it. We will not set optional cookies unless you accept them. You can change your choice at any time from the Cookie settings link in the footer.
Strictly necessary cookies
These cookies are required for the site to work. They store your cookie preferences and keep your session secure. They are exempt from consent under PECR Regulation 6(4) because they are essential to deliver the service you have requested.
Optional cookies
Optional cookies help us understand how the site is used and provide additional features such as analytics, accessibility tools and translation. We will only set them if you accept.
Shingles Vaccine (Shingrix)
From 1st September 2023, a new 2-dose shingles vaccine called Shingrix is being used. It is offered to healthy people turning 65 or 70 on or after that date. Because of limited vaccine supply and appointment availability, invitations are being sent in phases, following the official timeline from the UK Health Security Agency.
Who is eligible?
- Healthy people turning 65 or 70 (starting 2023).
- From 2028, people turning 60 and 65.
- From 2033, it will be routine to offer the vaccine at age 60.
- Once you become eligible, you remain eligible until your 80th birthday.
Special eligibility:
If you are 18 or over and have a severely weakened immune system, you are also eligible for the vaccine. This includes people with:
- Certain blood cancers (like leukaemia or lymphoma)
- HIV or AIDS
- Recent stem cell transplant, radiotherapy, chemotherapy, or organ transplant
- Those taking medicines that severely weaken the immune system
You will receive 2 doses of the vaccine, given between 8 weeks and 6 months apart.
If you’re unsure whether you’re eligible, please ask your GP or care team.
More information about the Shingles vaccine
Published: Oct 21, 2025